Skip to content
AnalystLens

Corteva, Inc. 8-K Report, Corporate Update (May 31, 2019)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed May 31, 2019
Period End
May 31, 2019
Security
CTVA
In the record · 2019–202610-K710-Q238-K84

CTVA filed 7 annual reports (10-K), 23 quarterly reports (10-Q) and 84 current reports (8-K) between 2019 and 2026.

  1. Leadership change8-K · Feb ’21Feb ’21
  2. Restructuring8-K · Aug ’22Aug ’22
  3. Impairment8-K · Nov ’23Nov ’23
  4. Leadership change8-K · Oct ’26Oct ’26

01—Abstract

Summary

Summary of the 8-K filed May 31, 2019. Cited figures are marked; the original filing is the authoritative source.

Corteva, Inc. (CTVA) filed a Current Report on Form 8-K on May 31, 2019, primarily to disclose the filing of a prospectus supplement related to its Registration Statement on Form S-3.

This filing pertains to the potential issuance of up to 6,200,000 shares of common stock. These shares may become outstanding upon the exercise, settlement, or vesting of awards granted under the company's 2019 Omnibus Incentive Plan, specifically for awards not eligible for registration on Form S-8. This action indicates Corteva's preparation for equity issuance related to its executive and employee compensation programs.

The filing of the prospectus supplement is a standard procedural step to ensure these shares can be legally offered and sold in the public market. Investors should note that this is a procedural filing, and the actual issuance of shares is contingent upon the exercise or vesting of existing awards, not an immediate sale of new equity by the company.

02—Key points

Key Highlights

  1. Corteva filed a prospectus supplement on May 31, 2019, regarding potential share issuances.
  2. The filing relates to up to 6,200,000 shares of common stock.
  3. These shares may be issued upon the exercise, settlement, or vesting of awards under the Corteva, Inc. 2019 Omnibus Incentive Plan.
  4. The shares are intended for awards not eligible for registration on Form S-8.
  5. A legal opinion from Skadden, Arps, Slate, Meagher & Flom LLP was filed as Exhibit 5.1.
  6. The company's Chief Financial Officer, Gregory R. Friedman, signed the report.
  7. This filing is procedural and related to equity compensation.

03—Questions

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The primary purpose of this 8-K filing is to report Corteva, Inc.'s filing of a prospectus supplement with the SEC. This supplement relates to the potential issuance of up to 6,200,000 shares of common stock tied to its 2019 Omnibus Incentive Plan.

  2. Does this mean Corteva is issuing new shares for sale to the public?

    Not directly. This filing pertains to shares that may become outstanding upon the exercise, settlement, or vesting of awards already granted under the company's incentive plan. It's a mechanism to register shares that will be issued to employees or other award recipients, rather than an immediate offering of new shares to the broader market.

  3. What is the Corteva, Inc. 2019 Omnibus Incentive Plan?

    This plan is an equity-based compensation program for the company's employees and executives. The shares mentioned in the filing are intended to cover potential issuances stemming from awards granted under this plan, such as stock options or restricted stock units, that require registration beyond the S-8 form.

  4. What is the significance of filing a prospectus supplement and a Registration Statement on Form S-3?

    Filing a prospectus supplement alongside a Registration Statement on Form S-3 allows the company to register shares that will be offered and sold in the future. In this case, it's to facilitate the issuance of shares under the incentive plan, ensuring compliance with securities regulations for these potential future issuances.

04—Continue

← View all 8-K filings